Monoclonal Antibody to Tumor Necrosis Factor-α Attenuates Plasma Interleukin-6 Levels in Porcine Gram-Negative Sepsis

Journal of Surgical Research

Volumn 57, Issue 5, 1994, Pages 625-631

  Mullen, Patrick G ^a   Fisher, Bernard J ^a   Walsh, Ciaran J ^a   Susskind, Brian M ^a   Leeper Woodford, Sandra K ^a   Jesmok, Gary J ^b   Fowler, Alpha A ^a   Sugerman, Harvey J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SECRETION; CONTROLLED STUDY; GRAM NEGATIVE SEPSIS; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PSEUDOMONAS AERUGINOSA;

ANIMAL; ANTIBODIES, MONOCLONAL; BACTEREMIA; BLOOD PRESSURE; HEART RATE; INFUSIONS, INTRAVENOUS; INTERLEUKIN-6; PSEUDOMONAS INFECTIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SWINE; TUMOR NECROSIS FACTOR;

EID: 0028148485     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1006/jsre.1994.1192     Document Type: Article

References (42)

1. Montgomery, A. B., Stager, M. A., Carrico, C. J., and Hudson, L. D. Causes of mortality in patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132: 485, 1985.
2. Seidenfeld, J. J., Pohl, D. F., Bell, R. C., Harris, G. D., and Jo-hanson, J. R. Incidence, site and outcome of infection in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 134: 12, 1986.
3. Centers for Disease Control. Increase in national hospital discharge survey rates for septicemia—United States, 1979-1987. MMWR 39: 31, 1990.
4. Michie, H. R., Spriggs, D. R., Manogue, K. R., et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280, 1988.
5. Dinarello, C. A., Cannon, J. G., Wolff, S. M., et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J. Exp. Med. 163: 1433, 1986.
6. Fong, Y., Moldawer, L. L., Marano, M., et al. Endotoxemia elicits increased circulating /S2-ifn/il-6 in man. J. Immunol. 142: 2321, 1989.
7. Le May, D. R., Le May, L. G., Kluger, M. J., and D’Alecy, L. G. Plasma profiles of IL-6 and TNF with fever-inducing doses of lipopolysaccharide in dogs. Am. J. Physiol. 259: R126, 1990.
8. Tracey, K. J., Beutler, B., Lowry, S. F., et al. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470, 1986.
9. Kohase, M., Henrikson-DeStefano, D., May, L. T., Vilcek, J., and Sehgal, P. B. Induction of ^2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 45: 659, 1986.
10. Kasid, A., Director, E. P., and Rosenberg, S. A. Regulation of interleukin-6 (IL-6) production by IL-2 and TNF-or in human peripheral blood mononuclear cells. Ann. N.Y. Acad. Sci. 557: 564, 1989.
11. Sehgal, P. B. Interleukin 6 in infection and cancer. Proc. Soc. Exp. Biol. Med. 195: 183, 1990.
12. Geiger, T., Andus, T., Klapproth, J., Hirano, T., Kishimoto, T., and Heinrich, P. Induction of rat acute-phase protein synthesis by interleukin-6 in vivo. Eur. J. Immunol. 18: 717, 1986.
13. Castell, J. V., Andus, T., Kunz, D., and Heinrich, P. C. Interleukin-6: The major regulator of acute-phase protein synthesis in man and rat. Ann. N. Y. Acad. Sci. 557: 87, 1989.
14. Kern, P., Hemraer, C. J., Van Damme, J., Gruss, H. J., and Dietrich, M. Elevated tumor necrosis factor alpha and interleukin*6 serum levels as markers for complicated plasmodium falciparum malaria. Am. J. Med. 87: 139, 1989.
15. Hirano, T., Matsuda, T., Turner, M., et al. Excessive production of interleukin-6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18: 1797, 1988.
16. Horii, Y., Muraguchi, A., Iwano, M., et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J. Immunol. 143: 3949, 1989.
17. Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., and Espe-vik, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169: 333, 1989.
18. Calandra, T., Gerain, J., Heumann, D., Baumgartner, J., and Glauser, M. P. High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value and interplay with other cytokines. Am. J. Med. 91: 23, 1991.
19. Hack, C. E., DeGroot, E. R., Felt-Bersma, R. J. F., et al. Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704, 1989.
20. Preiser, J. C., Schmartz, D., van der Linden, P., et al. Interleu-kin-6 administration has no acute hemodynamic or hematologic effect in the dog. Cytokine 3: 1, 1991.
21. Hesse, D. G., Tracey, K. J., Fong, Y., et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166: 147, 1988.
22. Walsh, C. J., Sugerman, H. J., Mullen, P. G., et al. Monoclonal antibody to tumor necrosis factor a attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. Arch. Surg. 127: 138, 1992.
23. 2-terminal amino acid sequence of a T-cell derived lympho-kine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83: 9679, 1986.
24. Flick, D. A., and Gifford, G. E. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 68: 167, 1984.
25. Leeper-Woodford, S. K., Carey, P. D., Byrne, K., et al. Tumor necrosis factor: Alpha and beta subtypes appear in circulation during onset of sepsis-induced lung injury. Am. Rev. Respir. Dis. 143: 1076, 1991.
26. Shalaby, M. R., Waage, A., Aarden, L. A., and Espevik, T. Endotoxin, tumor necrosis factor-a and interleukin-1 induce interleu-kin-6 production in vivo. Clin. Immunol. Immunopathol. 53: 488, 1989.
27. Pirotzky, E., Delattre, R. M., Hellegouarch, A., etal. Interleukin-6 production by tumor necrosis factor and lipopolysaccharide-stimulated rat renal cells. Clin. Immunol. Immunopathol. 56: 271, 1990.
28. Elias, J. A., and Lentz, V. II-1 and tumor necrosis factor syner-gistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 145: 161, 1990.
29. Fong, Y., Tracey, K. J., Moldawer, L. L., et al. Antibodies to cachectin/tumor necrosis factor reduce interleukin-1^ and inter-leukin-6 appearance during lethal bacteremia. J. Exp. Med. 170: 1627, 1989.
30. Engelberts, I., von Asmuth, E. J. U., van der Linden, C. J., and Buurman, W. A. The interrelation between TNF, IL-6 and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymph. Res. 10: 127, 1991.
31. Sironi, M., Breviaro, F., Prosperio, P., et al. IL-1 stimulates IL-6 production in endothelial cells. J. Immunol. 142: 549, 1989.
32. Marinkovic, S., Jahreis, G. P., Wong, G. G., and Baumann, H. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J. Immunol. 142: 808, 1989.
33. Bauer, J.T and Herrmann, F. Interleukin-6 in clinical medicine. Ann. Hematol. 62: 203, 1991.
34. Kharazmi, A., Nielsen, H., Rechnitzer, C., and Bendtzen, K. Interleukin-6 primes the human neutrophil and monocyte oxidative burst response. Immunol. Lett. 21: 177, 1989.
35. Borish, L., Rosenbaum, R., Albury, L-, and Clark, S. Activation of neutrophils by recombinant interleukin-6. Cell. Immunol. 121: 280, 1989.
36. Ruppert, J., and Peters, H. IL-6 and IL-1 enhance the accessory activity of human blood monocytes IL-6 and IL-1 enhance the accessory activity of human monocytes during differentiation to macrophages. J. Immunol. 146: 144, 1991.
37. Curran, R. D., Billiar, T. R., Stuehr, D. J., et al. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann. Surg. 212: 462, 1990.
38. Mullen, P. G., Windsor, A. C., Fisher, B. J., Fowler, A. A., and Sugerman, H. J. Interleukin-6 primes neutrophils for sustained respiratory burst in vitro. Br. J. Surg. 81: 466, 1992.
39. Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., and Abrams, J. S. Anti-il-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor challenge in mice. J. Immunol. 145: 4185, 1990.
40. Wong, G. C., and Clark, S. C. Multiple actions of interleukin-6 within a cytokine network. Immunol. Today 9: 137, 1988.
41. May, L. T., Torcia, G., Cozzolino, F., et al. Interleukin-6 gene expression in endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem. Biophys. Res. Commun. 159: 991, 1989.
42. Diana, D., and Sculier, J. P. Hemodynamic effects induced by intravenous administration of high doses of r-Met Hu IL-2 [ala 125] in patients with advanced cancer. Intensive Care Med. 16: 167, 1990.